Printer Friendly

A positive long-term view for Colgate-Palmolive.

* Colgate-Palmolive may be going through a painful restructuring program, but that didn't stop Marquis Investment Research from issuing a "buy" rating on the stock late last month.

Analyst Charles Georgas set his price target for Colgate at $59 (the stock was at $50 at press time), citing the company's "proactive" fourth-quarter restructuring plans and its valuation, among other factors.

"With 75% of worldwide sales outside the U.S., the company is wellestablished in high-growth developing markets," said Mr. Georgas in a note to clients. "We anticipate long-term growth in earnings per share in low double-digits and strong growth in key brands."

Mr. Georgas insisted that the stock's current valuation doesn't reflect Colgate's sustainable growth rate and level of risk.

"Colgate has outperformed the industry, sector, S&P 500 and its chief competitor (P&G), in terms of gross margin, operating margin and net margin based on a five-year average," said Mr. Georgas. "Colgate will continue to expand its margins as the company focuses on more profitable businesses as a result of the recent restructuring."
COPYRIGHT 2005 Rodman Publications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:As We Go To Press
Publication:Household & Personal Products Industry
Date:Jan 1, 2005
Words:174
Previous Article:What's in store for 2005?
Next Article:U.S. demand for I&I chemicals is on the rise: sales projected to exceed $9 billion by 2008.


Related Articles
Why Colgate keeps clicking: a wave of new products, attention to the bottom line and a talented management team all help to keep the company ahead of...
Who makes that? (the top 50).
A grand view in Jersey City.
Colgate acquires GABA; strengthens portfolio.
2. Colgate-Palmolive.
Cari-med acquires Colgate-Palmolive.
The Colgate, Tom's of Maine deal: did Tom's of Maine 'sell out' to a company out of sync with its core values?
Third quarter profit slip at Colgate-Palmolive.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters